Arizona Arthritis & Rheumatology Research   Report issue

For profit Phase 2
Founded: Phoenix AZ United States (2003)

Organization Overview

First Clinical Trial
2014
NCT02070302
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

Arizona Arthritis & Rheumatology Research, PLLC. | Benjamin Sucher

Active Ingredients

Drugs in Phase 2 Trials (1)

rimabotulinumtoxinB (Myobloc) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carpal Tunnel Syndrome (Phase 2)

Syndrome (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1